NCT06090799: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3032 in Healthy Subjects |
|
|
| Completed | 1 | 6 | RoW | SHR-3032, SHR-3032 Placebo | Guangdong Hengrui Pharmaceutical Co., Ltd | Prevention of Graft Rejection After Organ Transplantation | 03/24 | 04/24 | | |
NCT06601517: A Drug-Drug Interaction (DDI) Study of HDM1002 With Repaglinide, Atorvastatin, Digoxin and Rosuvastatin in Healthy Subjects and Overweight Subjects. |
|
|
| Not yet recruiting | 1 | 30 | RoW | Repaglinide, Atorvastatin, Digoxin, Rosuvastatin, HDM1002 | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Healthy Adult Subject, Overweight Subject | 02/25 | 04/25 | | |
NCT06762704: Evaluation of an Artificial Intelligence Model for the Prediction of Human Blastocyst Ploidy Without Invasive Procedures |
|
|
| Not yet recruiting | N/A | 1408 | RoW | Video recording | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Jiangxi Maternal and Child Health Hospital, Tangdu Hospital of Air Force Military Medical University, The First Affiliated Hospital of USTC (Anhui Provincial Hospital) | The Focus is to Validate the Accuracy of a Non-invasive Artificial Intelligence Model for the Prediction of the Human Blastocyst Ploidy, Preimplantation Genetic Testing (PGT) | 06/27 | 12/27 | | |
